KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Retained Earnings (2016 - 2025)

Globus Medical (GMED) has disclosed Retained Earnings for 15 consecutive years, with $15.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 323.67% year-over-year to $15.3 million, compared with a TTM value of $15.3 million through Dec 2025, up 323.67%, and an annual FY2025 reading of $15.3 million, up 323.67% over the prior year.
  • Retained Earnings was $15.3 million for Q4 2025 at Globus Medical, down from $1.3 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at $1.3 billion in Q3 2023 and bottomed at -$24.6 million in Q4 2022.
  • Average Retained Earnings over 5 years is $579.1 million, with a median of $525.8 million recorded in 2025.
  • The sharpest move saw Retained Earnings crashed 238.38% in 2021, then skyrocketed 72775.25% in 2022.
  • Year by year, Retained Earnings stood at $1.2 billion in 2021, then tumbled by 102.06% to -$24.6 million in 2022, then soared by 58.62% to -$10.2 million in 2023, then surged by 32.68% to -$6.9 million in 2024, then surged by 323.67% to $15.3 million in 2025.
  • Business Quant data shows Retained Earnings for GMED at $15.3 million in Q4 2025, $1.3 billion in Q3 2025, and $1.2 billion in Q2 2025.